{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:10:01Z","timestamp":1792602601792,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ahj.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T21:30:18Z","timestamp":1377725418000},"page":"622-628.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":301,"title":["Rheumatoid arthritis and cardiovascular disease"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct01594333","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Cynthia S.","family":"Crowson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine E.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.07.010_bb0005","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0015","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0030","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0035","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.amjmed.2010.05.017","article-title":"Outcomes in patients with rheumatoid arthritis and myocardial infarction","volume":"123","author":"Francis","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2377-12-41","article-title":"Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"12","author":"Zoller","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.33322","article-title":"Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?","volume":"64","author":"Bacani","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.21628","article-title":"Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations","volume":"54","author":"Liang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2010.05.007","article-title":"Subclinical peripheral arterial disease in rheumatoid arthritis","volume":"212","author":"Stamatelopoulos","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/keg083","article-title":"Rheumatoid arthritis and macrovascular disease","volume":"42","author":"Alkaabi","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.ahj.2013.07.010_bb0065","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/2012.jama.11741","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization","volume":"308","author":"Holmqvist","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0070","first-page":"495","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"69","author":"Myasoedova","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016110791112269","article-title":"Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors","volume":"8","author":"Toms","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0080","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0085","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis","volume":"50","author":"Maradit Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0090","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1002\/art.27629","article-title":"Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0095","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ahj.2013.07.010_bb0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0105","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","author":"Liang","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0110","first-page":"S14","article-title":"Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases","volume":"26","author":"Sokka","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0025-6196(11)60548-X","article-title":"Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease","volume":"84","author":"Lavie","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2013.07.010_bb0120","doi-asserted-by":"crossref","first-page":"681640","DOI":"10.4061\/2011\/681640","article-title":"Benefits of exercise in rheumatoid arthritis","volume":"2011","author":"Cooney","year":"2011","journal-title":"J Aging Res"},{"key":"10.1016\/j.ahj.2013.07.010_bb0125","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/art.24891","article-title":"Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial","volume":"61","author":"Lemmey","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0130","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.11216","article-title":"Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial","volume":"48","author":"de Jong","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0135","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/ard.59.8.615","article-title":"Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial","volume":"59","author":"van den Ende","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.22903","article-title":"Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis","volume":"57","author":"Neuberger","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002060-199501000-00004","article-title":"Effects of a modified dance-based exercise on cardiorespiratory fitness, psychological state and health status of persons with rheumatoid arthritis","volume":"74","author":"Noreau","year":"1995","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.ahj.2013.07.010_bb0150","first-page":"1940","article-title":"Preventive medical services among patients with rheumatoid arthritis","volume":"30","author":"Maradit Kremers","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0155","doi-asserted-by":"crossref","first-page":"R270","DOI":"10.1186\/ar4118","article-title":"Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis","volume":"14","author":"Desai","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ahj.2013.07.010_bb0160","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/ar3151","article-title":"Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population","volume":"12","author":"Van Doornum","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ahj.2013.07.010_bb0165","first-page":"867","article-title":"Glucocorticoids and insulin sensitivity in rheumatoid arthritis","volume":"31","author":"Dessein","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0170","first-page":"1810","article-title":"Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis\u2013a randomized study","volume":"34","author":"Hafstrom","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0180","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0185","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0190","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2013.07.010_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ahj.2008.12.014","article-title":"Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis","volume":"157","author":"Becker","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.07.010_bb0200","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0205","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2014a prospective, controlled study","volume":"8","author":"Georgiadis","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.ahj.2013.07.010_bb0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1538-7836.2009.03404.x","article-title":"Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)","volume":"7","author":"Ridker","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2013.07.010_bb0215","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ahj.2013.07.010_bb0220","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0225","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1136\/ard.2009.127597","article-title":"Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study","volume":"69","author":"Jamnitski","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0230","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.010_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","article-title":"Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study","volume":"55","author":"Angel","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2013.07.010_bb0240","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/kei033","article-title":"Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis","volume":"44","author":"Van Doornum","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ahj.2013.07.010_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.20393","article-title":"Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients","volume":"63","author":"Morris","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ahj.2013.07.010_bb0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3899\/jrheum.100717","article-title":"Tocilizumab for rheumatoid arthritis: a Cochrane systematic review","volume":"38","author":"Singh","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0260","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2013.07.010_bb0265","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/ard.2003.018333","article-title":"Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis","volume":"63","author":"Van Doornum","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0270","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0275","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.2010.142455","article-title":"Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study","volume":"70","author":"De Vera","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0280","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/ard.2010.136093","article-title":"Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry","volume":"70","author":"Arts","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0285","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/archinte.1993.00410210093010","article-title":"A reevaluation of aspirin therapy in rheumatoid arthritis","volume":"153","author":"Fries","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0290","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0295","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.01.024","article-title":"Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction","volume":"221","author":"Paakkanen","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2013.07.010_bb0305","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11033-010-0279-8","article-title":"Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease","volume":"38","author":"Sun","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ahj.2013.07.010_bb0310","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.010_bb0315","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0320","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0325","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"Schomig","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0330","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.0105-2896.2005.00256.x","article-title":"CD28 extinction in human T cells: altered functions and the program of T-cell senescence","volume":"205","author":"Vallejo","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ahj.2013.07.010_bb0335","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+CD28\u2212 T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.010_bb0340","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/art.1780400615","article-title":"Expansion of unusual CD4+ T cells in severe rheumatoid arthritis","volume":"40","author":"Martens","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0345","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/hc0502.103348","article-title":"T-cell\u2013mediated lysis of endothelial cells in acute coronary syndromes","volume":"105","author":"Nakajima","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.010_bb0350","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1073\/pnas.2233561100","article-title":"Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages","volume":"100","author":"Schonland","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0355","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/art.23287","article-title":"Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis","volume":"58","author":"Colmegna","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ahj.2013.07.010_bb0360","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20082251","article-title":"Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis","volume":"206","author":"Shao","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0365","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1073\/pnas.0811332106","article-title":"Telomerase insufficiency in rheumatoid arthritis","volume":"106","author":"Fujii","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ahj.2013.07.010_bb0370","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.109.854299","article-title":"Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity","volume":"120","author":"Spyridopoulos","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.010_bb0375","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrrheum.2009.180","article-title":"Rejuvenating the immune system in rheumatoid arthritis","volume":"5","author":"Weyand","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ahj.2013.07.010_bb0380","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11883-012-0295-3","article-title":"Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates?","volume":"15","author":"Ridker","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ahj.2013.07.010_bb0385","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"Genovese","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.07.010_bb0390","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2013.07.010_bb0395","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313004481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:51:08Z","timestamp":1757569868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313004481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002870313004481"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid arthritis and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}